Neonatal candidiasis. Our experience liposomal amphotericin B as treatment;Candidiasis neonatales y tratamiento con anfotericina B liposomal: Nuestra experiencia

Anales Espanoles de Pediatria

Volumn 51, Issue 3, 1999, Pages 273-280

  Carrasco Sánchez, Pilar ^a,b   Castillo Montero, Ma L L ^a   Bejarano Palma, A ^a   Lopez Sanz A ^a   Santano Gallinato, M ^a   Saenz Reguera C ^a   Duran De Vargas L ^a   Gonzalez Meneses A ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN MACARENA   (Spain)

^b NONE   (Spain)

Author keywords

Candida; LBW; Liposomal Amphotericin B; Newborn; Sepsis

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; FLUCYTOSINE;

ANEMIA; ARTICLE; CANDIDIASIS; CLINICAL ARTICLE; DRUG EFFICACY; HOSPITAL INFECTION; HUMAN; HYPOTENSION; LOW BIRTH WEIGHT; MALE; NEWBORN; NEWBORN INFECTION; NEWBORN SEPSIS; PREMATURITY;

AGE FACTORS; AMPHOTERICIN B; ANTI-BACTERIAL AGENTS; ANTIBIOTICS, ANTIFUNGAL; ANTIFUNGAL AGENTS; BODY WEIGHT; CANDIDIASIS; CROSS INFECTION; DRUG CARRIERS; DRUG THERAPY, COMBINATION; FLUCYTOSINE; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; LIPOSOMES; RISK FACTORS; TIME FACTORS;

EID: 0032705899     PISSN: 03024342     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Baley JE, Kliegman RM, Boxerbaum B, Fanaroff AA. Fungal Colonization in the Very Low Birth Weight Infant. Pediatrics 1986; 78:225-232.
2. Rowen JL, Atkins JT, Levy ML, Baer SC, Baker CJ. Invasive fungal dermatitis in the <=1000 gram neonate. Pediatrics 1995; 95:682-687.
3. Botas CM, Kurlat I, Young SM, Sola A. Disseminated Candidal infections and intravenous hydrocortisone in preterm infants. Pediatrics 1995; 95:883-887.
4. Baley JE, Meyers C, Kliegman RM, Jacobs MR, Blumer JL. Pharmacokinetics, outcome of treatment, and toxic effects of amphotericin B and 5-fluorcytosine in neonates. J Pediatrics 1990; 116:791-797.
5. Pallister CJ, Johnson EM, Warnock DW et al. In vitro effects of liposome-encapsulated amphotericin B (AmBisome) and amphotericin B-deoxycholate (Fungizone) on the phagocytic and candidacidal funtion of human polymorphonuclear leucocytes. J Antim Chemother 1992; 30:313-320.
6. Rabalais GP, Samiec TD, Bryant KK, Lewis JJ. Invasive candidiasis in infants weighing more than 2500 grams at birth admitted to a neonatal intensive care unit. Pediatr Infect Dis J 1996; 15:348-352.
7. Butler KM, Baker CJ. Candida: un microorganismo patógeno de importancia cada vez mayor en las casas cuna. Pediatr Clin North Am 1988; 3:589-611.
8. Faix RG, Kovarik SM, Shaw TR, Johnson RV. Mucocutaneous and Invasive Candidiasis among Very Low Birth Weight (<1500 grams) Infants in Intensive Care Nurseries: a prospective study. Pediatrics 1989; 83:101-107.
9. Kaplan M, Eidelman AI, Dollberg L, Abu-Dalu K. Necrotizing Bowel dissease with Candida peritonitis following severe Neonatal Hipotermia. Act Pediatr Scand 1990; 79:976-979.
10. Faix RG. Systemic candida infections in infants in intensive care nurseries: high incidence of central nervous system involvement. J Pediatr 1984; 105:616-622.
11. Ocete E, Loscertales M, Ruiz A, Carreño J, Mantas JA, Narbona E. Incidencia de infecciones por Candida en el recién nacido de muy bajo peso. Importancia de un diagnóstico precoz y valoración de las actitudes terapéuticas. An Esp Pediatr 1993; 39:58-60.
12. Wiest DB, Fowler SL, Garner SS, Simons DR. Fluconazol in neonatal disseminated candidiasis. Arch Dis Child 1991; 66:1002.
13. Bhandari V, Narang A. Oral itraconazol therapy for disseminated candidiasis in low birth weight infants. J Pediatr 1992; 120:330.
14. Anaissie E, Paetznick V, Proffitt R, Adler-Moore J, Bodey GP. Comparison of the in vitro antifungal activity of free and liposome-encapsulated amphotericin B. Eur J Clin Microbiol Infect Dis 1991; 10:665-668.
15. Adler-Moore JP, Fujii G, Lee MJA et al. In vitro and in vivo interactions of AmBisome with pathogenic fungi. J Liposome Res 1993; 3:151-156.
16. Adler-Moore JP, Proffitt RT. Development, characterization, efficacy and mode of action of AmBisome, a unilamellar liposomal formulation of amphotericin B. J Liposome Res 1993; 3:429-450.
17. Zoubeck A, Emminger W, Emminger-Schmidmeiner W et al. Conventional vs. Liposomal Amphotericin B in immunocompromised children. Pediatr Hemat Oncol 1992; 9:187-190.
18. López-Berestein G, Bodey GP, Fainstein V, Keating M, Frankel LS, Zeluff B, Gentry L, Mehta K. Treatment of systemic Fungal Infections with liposomal Amphotericin B. Arch Intern Med 1989; 149:2533-2536.
19. Ringden O, Meunier F, Tollemar J, et al. Efficacy of amphotericin B encapsulated in liposomes (AmBisome) in the treatment of invasive fungal infections in immunocompromised patients. J Antimicrob Chemother 1991; 28:73-82.
20. Ringdén O, Tollemar J, et al. High cure rate of invasive fungal infections in immunocompromised children using AmBisome. Transplantation Proceedings 1994; 26:175-177.
21. Lackner H, Schwinger W, Urban C et al. Liposomal amphotericin B (Ambisome) for treatment of disseminated fungal infections en two infants of very low birth weight. Pediatrics 1992; 89:1249-1261.
22. Sievers R, Neubauer P, Natzschka J. Liposomal amphotericin B in the treatment of a disseminated candida infection with encephalitis and osteoarthritis in a preterm neonate. Monatsschr Kinderheilkd 1994; 142:266-268.
23. Recuenco I, Ruano M, Torrecilla A, Sosa P, Recuero R, Alonso E, Jiménez ME. Experiencia en el uso de anfotericina B Liposomal en un hospital pediátrico. Farm Clin 1993; 10:158-164.
24. Houmeau, Monfort-Gouraud M, Boccara JF, Badoual J. Méningite à Candida, chez un prématuré, traité par Amphotericine B liposomale et flucytosine. Arch Fr Pediatr 1993; 50:227-230.
25. Laing RBS, Milne LJR, Leen CLS, et al. Anaphylactic reactions to liposomal amphotericin. Lancet 1994; 344:682.
26. Aguado JM, Hidalgo M, Moya I, et al. Ventricular arrhythmias with conventional and liposomal amphotericin. Lancet 1993; 342:1239.
27. Tollemar J, Ringdén O. Lipid formulations of Amphotericin B. Less toxicity but at what economic cost?. Drug Safety 1995; 13:207-218.
28. Levine SJ, Walsh TJ, Martínez A, Eichacker PO, López-Berestein G, Natanson Ch Cardiopulmonary Toxicity after Liposomal Amphotericin B Infusion. Ann Intern Med 1991; 114:664-666.
29. Hay RJ. Liposomal amphotericin B, AmBisome. J Infect 1994: 28:35-43.
30. Baquero Artigao F, Salas Hernández S, Quero Jiménez J. La anfotericina B liposomal (Ambisome) en el tratamiento de las infecciones fúngicas sistémicas en el neonato. A propósito de un caso. An Esp Ped 1996; 45:209-221.